Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
3,612
-23
-0.6% -$8.2K 0.18% 92
2025
Q4
$1.19M Sell
3,635
-100
-3% -$31.7K 0.16% 93
2025
Q3
$1.05M Sell
3,735
-10
-0.3% -$2.9K 0.15% 97
2025
Q2
$1.05M Hold
3,745
0.16% 98
2025
Q1
$1.17M Hold
3,745
0.19% 87
2024
Q4
$976K Sell
3,745
-56
-1% -$16.6K 0.16% 95
2024
Q3
$1.22M Sell
3,801
-200
-5% -$65.4K 0.2% 82
2024
Q2
$1.25M Buy
4,001
+11
+0.3% +$3.23K 0.22% 83
2024
Q1
$1.13M Sell
3,990
-8
-0.2% -$2.34K 0.2% 83
2023
Q4
$1.15M Buy
3,998
+278
+7% +$75.7K 0.22% 82
2023
Q3
$1,000K Sell
3,720
-57
-2% -$14.2K 0.21% 81
2023
Q2
$839K Sell
3,777
-3
-0.1% -$696 0.17% 90
2023
Q1
$914K Buy
3,780
+159
+4% +$39K 0.19% 87
2022
Q4
$951K Sell
3,621
-12
-0.3% -$3.22K 0.2% 88
2022
Q3
$819K Hold
3,633
0.18% 88
2022
Q2
$884K Buy
3,633
+1,998
+122% +$490K 0.19% 94
2022
Q1
$395K Sell
1,635
-223
-12% -$51.2K 0.08% 129
2021
Q4
$418K Sell
1,858
-11
-0.6% -$2.32K 0.08% 133
2021
Q3
$397K Sell
1,869
-23
-1% -$5.29K 0.08% 135
2021
Q2
$461K Buy
1,892
+60
+3% +$14.8K 0.1% 117
2021
Q1
$456K Sell
1,832
-87
-5% -$20.8K 0.11% 112
2020
Q4
$441K Buy
1,919
+38
+2% +$8.76K 0.12% 105
2020
Q3
$478K Sell
1,881
-6
-0.3% -$1.49K 0.16% 88
2020
Q2
$445K Sell
1,887
-66
-3% -$15.1K 0.16% 89
2020
Q1
$396K Buy
1,953
+9
+0.5% +$1.97K 0.41% 45
2019
Q4
$469K Buy
+1,944
New +$429K 0.46% 40

Other funds holding AMGN

Live Oak Private Wealth's AMGN Position: Q1 2026 in Review

Live Oak Private Wealth reduced its Amgen (AMGN) stake by 0.63% in Q1 2026, selling an estimated $8.2K and leaving 3,612 shares worth $1.27M. The position accounts for 0.18% of the portfolio, ranked #92.

Live Oak Private Wealth first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Live Oak Private Wealth held 3,612 shares of Amgen worth $1.27M as of Q1 2026.
  • Live Oak Private Wealth sold 23 Amgen shares in Q1 2026, an estimated $8.2K.
  • Amgen made up 0.18% of Live Oak Private Wealth's portfolio in Q1 2026, its #92 holding.
  • Live Oak Private Wealth first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Live Oak Private Wealth's 13F filing for Q1 2026, filed 20 Apr 2026.